While the trial demonstrated a significant reduction in TRAb and total IgG serum levels, improvements in proptosis and Clinical Activity Scores (CASs) did not reach statistical significance at 12 weeks [ 85 ].
1
—
—
While the trial demonstrated a significant reduction in TRAb and total IgG serum levels, improvements in proptosis and Clinical Activity Scores (CASs) did not reach statistical significance at 12 weeks [ 85 ].